Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dermatomyositis With Myopathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT04972760
What this trial is testing

Baricitinib in Patients With Relapsing or naïve Dermatomyositis

Who this might be right for
Dermatomyositis
Assistance Publique - Hôpitaux de Paris 62
Large-scale testing (Phase 3)Study completedNCT01165008
What this trial is testing

Anakinra in Myositis

Who this might be right for
PolymyositisDermatomyositisInclusion Body Myositis
Karolinska Institutet
Testing effectiveness (Phase 2)WithdrawnNCT02980198
What this trial is testing

Study of IFN-K in Dermatomyositis

Who this might be right for
Dermatomyositis
Neovacs
Large-scale testing (Phase 3)Study completedNCT02971683
What this trial is testing

Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy

Who this might be right for
PolymyositisDermatomyositisAutoimmune Necrotizing Myopathy+2 more
Bristol-Myers Squibb 149
Large-scale testing (Phase 3)Ended earlyNCT03686969
What this trial is testing

Study Evaluating Efficacy and Safety of Octanorm in Patients With Dermatomyositis

Who this might be right for
Dermatomyositis
Octapharma 1
Large-scale testing (Phase 3)Study completedNCT05523167
What this trial is testing

Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

Who this might be right for
Active Idiopathic Inflammatory MyopathyMyositisDermatomyositis+3 more
argenx 265
Not applicableStudy completedNCT05027152
What this trial is testing

Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties

Who this might be right for
Idiopathic Inflammatory MyopathyDermatomyositisPolymyositis
Federal University of Espirito Santo 2
Early research (Phase 1)Looking for participantsNCT07115745
What this trial is testing

Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

Who this might be right for
Refractory Autoimmune Diseases
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 125
Testing effectiveness (Phase 2)Study completedNCT00004357
What this trial is testing

Absorption of Corticosteroids in Children With Juvenile Dermatomyositis

Who this might be right for
Vasculitis, HypersensitivityConnective Tissue DiseasesDermatomyositis+1 more
Northwestern University 6
Large-scale testing (Phase 3)Looking for participantsNCT05895786
What this trial is testing

Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

Who this might be right for
Myositis
Pfizer 318
Large-scale testing (Phase 3)Ended earlyNCT04999020
What this trial is testing

Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis

Who this might be right for
Dermatomyositis
Alexion Pharmaceuticals, Inc. 38
Not applicableActive Not RecruitingNCT01171573
What this trial is testing

Investigating Genes in Patients With Polymyositis and Dermatomyositis

Who this might be right for
Myositis
Northern Care Alliance NHS Foundation Trust 1,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07122648
What this trial is testing

Phase 2 Trial to Evaluate the Efficacy, Safety of Allogeneic Mitochondria (PN-101) in Patients With Refractory Polymyositis or Dermatomyositis

Who this might be right for
PolymyositisDermatomyositis
Paean Biotechnology Inc. 36
Not applicableStudy completedNCT07138157
What this trial is testing

Comparison Of The Effects Of Two Different Exercise Training Based On Internal And External Focus In Children and Adolescents With Rheumatic Diseases

Who this might be right for
Juvenile DermatomyositisRheumatic DiseasesJuvenile Idiopathic Arthritis (JIA)+1 more
Istanbul University - Cerrahpasa 28
Testing effectiveness (Phase 2)Ended earlyNCT02466243
What this trial is testing

Safety, Tolerability, and Efficacy of JBT-101 in Subjects With Dermatomyositis

Who this might be right for
Dermatomyositis
Corbus Pharmaceuticals Inc. 22
Large-scale testing (Phase 3)Ended earlyNCT04044690
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM)

Who this might be right for
Dermatomyositis
CSL Behring 134
Testing effectiveness (Phase 2)Study completedNCT05695950
What this trial is testing

A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis

Who this might be right for
Dermatomyositis
Lakefront Biotherapeutics NV 40
Testing effectiveness (Phase 2)Looking for participantsNCT07800871
What this trial is testing

FT839 in Autoimmune Diseases

Who this might be right for
ANCA-Associated Vasculitis (AAV)Idiopathic Inflammatory Myositis (IIM)Rheumatoid Arthritis (RA)+2 more
Fate Therapeutics 446
Large-scale testing (Phase 3)Study completedNCT05437263
What this trial is testing

Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis

Who this might be right for
Dermatomyositis
Priovant Therapeutics, Inc. 241
Testing effectiveness (Phase 2)Ended earlyNCT01148810
What this trial is testing

Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis

Who this might be right for
PolymyositisDermatomyositis
Novartis Pharmaceuticals 18
Next Page